Quick Answer
Aclaris Therapeutics, Inc. reported Gross Profit of $3.24 million for the year ending 2018.
- Aclaris Therapeutics, Inc. showed an increase of +580.9% in Gross Profit from 2017 to 2018.
- This data is from Aclaris Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2019.
- XBRL data for this metric is available from 2017 to 2018 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $231.0 thousand | Q4 2017: $245.0 thousand | Q1 2018: $151.0 thousand | Q2 2018: $2.50 million | Q3 2018: $435.0 thousand | Q4 2018: $160.0 thousand.
- Historical annual values: Fiscal year 2018: $3.24 million | Fiscal year 2017: $476.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: